Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Regencell Bioscience Holdings Ltd (RGC)

Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,744,030
  • Shares Outstanding, K 13,013
  • Annual Sales, $ 0 K
  • Annual Income, $ -4,300 K
  • EBIT $ 0 M
  • EBITDA $ -4 M
  • 60-Month Beta 2.62
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 966.58

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/17
See More
  • Average Estimate 0.34
  • Number of Estimates 6
  • High Estimate 0.39
  • Low Estimate 0.30
  • Prior Year 0.33
  • Growth Rate Est. (year over year) +3.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.89 +749.80%
on 05/19/25
67.09 unch
on 06/16/25
+56.75 (+548.71%)
since 05/16/25
3-Month
0.33 +19,958.38%
on 03/17/25
67.09 unch
on 06/16/25
+66.76 (+20,101.43%)
since 03/14/25
52-Week
0.08 +84,039.27%
on 07/22/24
67.09 unch
on 06/16/25
+66.96 (+53,346.96%)
since 06/11/24

Most Recent Stories

More News
Top 10 Trending Stocks on Yahoo Finance Right Now

In a day full of surprises, Yahoo Finance’s “Trending Now” leaderboard offers a snapshot of the stocks that investors can’t stop clicking on. The list cuts across sectors and market caps, with...

HBIO : 0.4892 (-3.85%)
LCID : 2.26 (+7.62%)
ANET : 94.80 (+2.65%)
AI : 24.24 (+2.02%)
BBY : 70.52 (+1.32%)
SBET : 13.49 (+46.47%)
UBER : 85.74 (+2.16%)
ELF : 127.02 (+1.41%)
CRM : 263.44 (+1.95%)
RGC : 63.00 (+302.30%)
Small Cap News Movers: Your Daily Digest of Stocks Making Moves on Market News

In today’s edition of Small Cap News Movers, we spotlight some of the most active and news-driven small-cap stocks. From biotech breakthroughs to tech partnerships and restructuring announcements, these...

CECO : 28.17 (+1.51%)
JAGX : 3.49 (-0.72%)
EVLV : 5.23 (+3.56%)
LEG : 9.34 (+1.08%)
PONY : 12.30 (+4.41%)
RGC : 63.00 (+302.30%)
Regencell Bioscience (NASDAQ: RGC): 5 Min Deep Dive

In the volatile world of small-cap stocks, few names have grabbed investor attention like Regencell Bioscience Holdings Ltd (NASDAQ: RGC). Once a thinly traded micro-cap, RGC has exploded in recent weeks,...

RGC : 63.00 (+302.30%)
Regencell, GlucoTrack, TC Biopharm, AbbVie, Actinium: 5 Health Care Stocks That Lit Up Retail Discussions Last Week

Investors reacted to insider buying, clinical trial updates, and strategic business shifts that happened in the week ended March 21, 2025.

GCTK : 5.9900 (+5.20%)
TCBP : 0.5000 (-67.53%)
ABBV : 191.42 (+0.18%)
ATNM : 1.5400 (+3.36%)
RGC : 63.00 (+302.30%)
Regencell Bioscience Stock Is Up Over 260% This Year — Are Retail Traders Riding The Wave Or Watching From The Sidelines?

The Hong Kong-based company focuses on researching, developing, and commercializing traditional Chinese medicine, targeting neurocognitive disorders and degeneration.

RGC : 63.00 (+302.30%)
Regencell Bioscience’s Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy Trial

Regencell Bioscience Holdings Limited (Nasdaq: RGC) (“ Regencell ”) today announced its interim results from its second efficacy trial.

RGC : 63.00 (+302.30%)
Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period

Regencell Bioscience Holdings Limited (NASDAQ: RGC):

RGC : 63.00 (+302.30%)
Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO

Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”), an early-stage bioscience company focusing on the research, development and commercialization of Traditional...

RGC : 63.00 (+302.30%)
Regencell Describes Their Traditional Chinese Medicine ("TCM") Treatments and Recent Efficacy Trial Results in New Video Interview on SNN Network

LOS ANGELES, CA / ACCESSWIRE / March 1, 2022 / SNN Network, The Official Small-, Micro- and Nano-Cap News Source™, today published a new Video Interview with the team from Regencell Bioscience Holdings...

RGC : 63.00 (+302.30%)
Regencell Bioscience’s Investigational Liquid-Formula RGC-COV19TM Shows Effectiveness Through Its Enrolled Patients in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-day Treatment Period in its EARTH Efficacy Trial

Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“ Regencell ” or the “ Company ”) today announced the results from an analysis of a total of 37 individuals enrolled in its E valuation and...

RGC : 63.00 (+302.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Regencell Bioscience Holdings Limited is an early-stage bioscience company which focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum...

See More

Key Turning Points

3rd Resistance Point 17.82
2nd Resistance Point 17.17
1st Resistance Point 16.42
Last Price 63.00
1st Support Level 15.01
2nd Support Level 14.36
3rd Support Level 13.61

See More

52-Week High 67.09
Last Price 63.00
Fibonacci 61.8% 41.49
Fibonacci 50% 33.58
Fibonacci 38.2% 25.68
52-Week Low 0.08

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
OSZAR »